# FDA Inspection 1162090 - OneBlood Inc. - February 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/932f4880-142c-4a7d-9f2e-54eb167c3f17
Source feed: FDA_Inspections

> FDA Inspection 1162090 for OneBlood Inc. on February 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162090
- Company Name: OneBlood Inc.
- Inspection Date: 2022-02-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162090 - 2022-02-10](https://www.keypedia.com/records/fda_inspections/oneblood-inc/f203f157-c48a-4a54-a72a-7bbbfebe4d74)
- [FDA Inspection 1081408 - 2019-01-30](https://www.keypedia.com/records/fda_inspections/oneblood-inc/e18b5905-d2ff-4755-aead-ee1199d758a5)
- [FDA Inspection 1011644 - 2017-03-15](https://www.keypedia.com/records/fda_inspections/oneblood-inc/273e0862-b736-4d9d-949f-994ece91cbad)
- [FDA Inspection 913501 - 2015-02-11](https://www.keypedia.com/records/fda_inspections/oneblood-inc/27c98623-d8ba-493e-a0b9-d7cd8421b533)
- [FDA Inspection 827724 - 2013-04-17](https://www.keypedia.com/records/fda_inspections/oneblood-inc/8eac856e-e3f4-4319-baaf-4b5fd571d881)

Company: https://www.keypedia.com/companies/oneblood-inc/d3916248-6b43-46b4-b2d6-7579dc3341d9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d